These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 30959519

  • 1. Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis.
    Tashiro M, Takazono T, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Kakeya H, Ando T, Ogawa K, Kishi K, Tokimatsu I, Hayashi Y, Fujiuchi S, Yanagihara K, Miyazaki Y, Ichihara K, Mukae H, Kohno S, Izumikawa K.
    Clin Infect Dis; 2020 Feb 14; 70(5):835-842. PubMed ID: 30959519
    [Abstract] [Full Text] [Related]

  • 2. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
    Takeda K, Suzuki J, Watanabe A, Arai T, Koiwa T, Shinfuku K, Narumoto O, Kawashima M, Fukami T, Tamura A, Nagai H, Matsui H, Kamei K.
    Med Mycol; 2021 Apr 06; 59(4):327-334. PubMed ID: 32642756
    [Abstract] [Full Text] [Related]

  • 3. [An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
    Tomioka H, Kaneda T, Kida Y, Kaneko M, Fujii H, Hayashi M, Tomii K, Tada K, Suzuki Y, Karino T.
    Kansenshogaku Zasshi; 2011 Nov 06; 85(6):644-51. PubMed ID: 22250455
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Two cases of pulmonary aspergilosis, which deteriorated with generic itraconazole].
    Saito W, Shishikura Y, Nishimaki K, Kikuchi T, Sasamori K, Kikuchi Y, Miki H.
    Kansenshogaku Zasshi; 2014 Jul 06; 88(4):469-73. PubMed ID: 25199382
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.
    Bongomin F, Harris C, Hayes G, Kosmidis C, Denning DW.
    PLoS One; 2018 Jul 06; 13(4):e0193732. PubMed ID: 29634721
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-fungal agents in the treatment of chronic pulmonary aspergillosis: Systematic review and a network meta-analysis.
    Sehgal IS, Dhooria S, Prasad KT, Muthu V, Aggarwal AN, Chakrabarti A, Agarwal R.
    Mycoses; 2021 Sep 06; 64(9):1053-1061. PubMed ID: 34031920
    [Abstract] [Full Text] [Related]

  • 11. Effective plasma concentrations of itraconazole and its active metabolite for the treatment of pulmonary aspergillosis.
    Nakamura Y, Matsumoto K, Sato A, Morita K.
    J Infect Chemother; 2020 Feb 06; 26(2):170-174. PubMed ID: 31481305
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study.
    Yoshida K, Kurashima A, Kamei K, Oritsu M, Ando T, Yamamoto T, Niki Y.
    J Infect Chemother; 2012 Jun 06; 18(3):378-85. PubMed ID: 22526387
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.
    Saito T, Fujiuchi S, Tao Y, Sasaki Y, Ogawa K, Suzuki K, Tada A, Kuba M, Kato T, Kawabata M, Kurashima A, Sakatani M, NHO Pulmonary Fungosis Research Group.
    Infection; 2012 Dec 06; 40(6):661-7. PubMed ID: 22956473
    [Abstract] [Full Text] [Related]

  • 16. Treatment of chronic pulmonary aspergillosis with voriconazole: review of a case series.
    Cucchetto G, Cazzadori A, Conti M, Cascio GL, Braggio P, Concia E.
    Infection; 2015 Jun 06; 43(3):277-86. PubMed ID: 25432571
    [Abstract] [Full Text] [Related]

  • 17. Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A systematic review and meta-analysis.
    Olum R, Baluku JB, Kazibwe A, Russell L, Bongomin F.
    PLoS One; 2020 Jun 06; 15(10):e0240374. PubMed ID: 33052954
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Antifungal susceptibility of Candida species isolated from patient with invasive fungal peritonitis and investigation on clinical breakpoints of itraconazole].
    Yamagishi Y, Terada M, Ohki E, Mikamo H.
    Jpn J Antibiot; 2009 Oct 06; 62(5):415-34. PubMed ID: 20055119
    [Abstract] [Full Text] [Related]

  • 20. High-throughput simultaneousquantification offive azole anti-fungal agents and one active metabolite in human plasma using ultra-high-performance liquid chromatography coupled to tandem mass spectrometry.
    Tanaka R, Shiraiwa K, Takano K, Ogata M, Honda S, Yoshida N, Okuhiro K, Yoshida M, Narahara K, Kai M, Tatsuta R, Itoh H.
    Clin Biochem; 2022 Jan 06; 99():87-96. PubMed ID: 34715112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.